Aug 26, 2019
NanoViricides, Inc. Has Filed its Annual Report, Company Advancing Rapidly Towards First IND
May 02, 2019
Genital Herpes Treatment Drugs: Global Market Insights & Projections, 2016 to 2026
Apr 16, 2019
NanoViricides Submits Pre-IND Briefing Documents to the US FDA
Mar 26, 2019
NanoViricides has Requested a Pre-IND Meeting with the US FDA
Feb 14, 2019
Genital Herpes Market Insights, Epidemiology and Market Forecasts Report 2019 Featuring Novartis, GlaxoSmithKline, Genocea Biosciences, AiCuris & Maruho
Feb 11, 2019
NanoViricides President Dr. Diwan to Present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm
Feb 04, 2019
NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials
Oct 15, 2018
NanoViricides Has Filed its Annual Report, Company Reports Strong Progress in Advancement of HerpeCide Program
Aug 07, 2018
NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study
Mar 27, 2018
Varicella Zoster Infection Treatment Market is Expected to Register a 4.2% CAGR From 2017 to 2027
Mar 19, 2018
NanoViricides Drug Candidates to be Tested in Animal Models of Dermal, Ocular and Genital Herpes Virus Infection at the University of Wisconsin
Feb 21, 2018
NanoViricides Files Quarterly Report for Period Ending December 31, 2017
Dec 18, 2017
Herpes: Patented Natural Treatments Stop the Herpes Outbreaks
Nov 21, 2017
The Herpes Vaccine in Development, and What to do While You Wait
Nov 20, 2017
NanoViricides Files Quarterly Report for Period Ending September 30, 2017
Nov 06, 2017
NanoViricides Provides Further Details on Its Herpes-Induced Acute Retinal Necrosis Animal Study to be Presented On November 10th at the Annual Meeting of the Ocular Microbiology and Immunology Group (OMIG) of the American Academy of Ophthalmology
Nov 06, 2017
Side-Effects of Antiviral Drugs? Lilac Corp Proposes a Great Alternative
Sep 29, 2017
NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials
Jun 26, 2017
NanoViricides' Poster "Novel Nanoviricides® Highly Effective Against Varicella Zoster Virus in Cell Culture" to be Presented Today at the 2017 Annual Meeting of American Society of Virology
Jun 20, 2017
NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of Virology